[go: up one dir, main page]

PE20090718A1 - Derivados de espiroindolinona - Google Patents

Derivados de espiroindolinona

Info

Publication number
PE20090718A1
PE20090718A1 PE2008000875A PE2008000875A PE20090718A1 PE 20090718 A1 PE20090718 A1 PE 20090718A1 PE 2008000875 A PE2008000875 A PE 2008000875A PE 2008000875 A PE2008000875 A PE 2008000875A PE 20090718 A1 PE20090718 A1 PE 20090718A1
Authority
PE
Peru
Prior art keywords
diona
tetrahydrospiro
indol
chlorophenyl
triazine
Prior art date
Application number
PE2008000875A
Other languages
English (en)
Inventor
Jin-Jun Liu
Zhuming Zhang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20090718A1 publication Critical patent/PE20090718A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

REFERIDA A UN COMPUESTO DE FORMULA I, DONDE X ES H, HALOGENO, CIANO, ENTRE OTROS; R1, R2, R3 Y R4 SON CADA UNO ALQUILO INFERIOR, ALQUENILO INFERIOR, ARILO, ENTRE OTROS; R ES H, ALQUILO INFERIOR SUSTITUIDO O NO. SON COMPUESTOS PREFERIDOS: (6'R,3R,8'S)-6-CLORO-8'-(3-CLOROFENIL)-6'-(5-FLUOR-2-METILFENIL)-2'-METIL-6',7',8',9'-TETRAHIDROESPIRO[3H-INDOL-3,7'-(2H-PIRIDO[2,1-c][1,2,4]TRIAZINA)]-2,3'(1H)-DIONA, (6'R,3R,8'S)-6-CLORO-8'-(3-CLOROFENIL)-2'-(3-DIMETILAMINO-PROPIL)-6'-(1-METILENO-PROPIL)-6', 7',8',9'-TETRAHIDROESPIRO-[3H-INDOL-3,7'-(2H-PIRIDO[2,1-c][1,2,4]TRIAZINA)-2,3'(1H)-DIONA; ENTRE OTROS. TAMBIEN SE REFIERE A UNA FORMULACION PARA UNA SOLA UNIDAD DE DOSIFICACION ORAL. DICHOS COMPUESTOS TIENEN ACTIVIDAD INHIBIDORA DE LA INTERACCION MDM2-p53 Y SON UTILES EN EL TRATAMIENTO DE TRANSTORNOS DE PROLIFERACION CELULAR COMO EL CANCER
PE2008000875A 2007-05-23 2008-05-21 Derivados de espiroindolinona PE20090718A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93136807P 2007-05-23 2007-05-23

Publications (1)

Publication Number Publication Date
PE20090718A1 true PE20090718A1 (es) 2009-06-20

Family

ID=39645560

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000875A PE20090718A1 (es) 2007-05-23 2008-05-21 Derivados de espiroindolinona

Country Status (16)

Country Link
US (1) US7834179B2 (es)
EP (1) EP2152714B1 (es)
JP (1) JP2010527954A (es)
KR (1) KR20090130319A (es)
CN (1) CN101679448A (es)
AR (1) AR066659A1 (es)
AT (1) ATE549340T1 (es)
AU (1) AU2008253117A1 (es)
BR (1) BRPI0812155A2 (es)
CA (1) CA2687160A1 (es)
ES (1) ES2382139T3 (es)
IL (1) IL202020A0 (es)
MX (1) MX2009012595A (es)
PE (1) PE20090718A1 (es)
TW (1) TW200901994A (es)
WO (1) WO2008141975A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776875B2 (en) * 2007-12-19 2010-08-17 Hoffman-La Roche Inc. Spiroindolinone derivatives
US7723372B2 (en) 2008-03-19 2010-05-25 Hoffman-La Roche Inc. Spiroindolinone derivatives
US8217051B2 (en) * 2009-02-17 2012-07-10 Hoffmann-La Roche Inc. Spiroindolinone derivatives
PH12012500870A1 (en) 2009-11-12 2012-11-26 Univ Michigan Regents Spiro-oxindole mdm2 antagonists
JO2998B1 (ar) 2010-06-04 2016-09-05 Amgen Inc مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان
FR2967072B1 (fr) 2010-11-05 2013-03-29 Univ Dundee Procede pour ameliorer la production de virus et semences vaccinales influenza
PE20140408A1 (es) 2010-11-12 2014-04-10 Univ Michigan Derivados espiro-oxindol como antagonistas de mdm2
CA2829188C (en) 2011-03-10 2016-10-18 Daiichi Sankyo Company, Limited Dispiropyrrolidine derivatives
EP2707372B1 (en) 2011-05-11 2016-12-21 The Regents Of The University Of Michigan Spiro-oxindole mdm2 antagonists
US9376425B2 (en) 2011-09-27 2016-06-28 Amgen, Inc. Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
TWI586668B (zh) 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
WO2014089904A1 (en) 2012-12-10 2014-06-19 Abbvie Inc. Triazinone compounds
WO2014100065A1 (en) 2012-12-20 2014-06-26 Merck Sharp & Dohme Corp. Substituted imidazopyridines as hdm2 inhibitors
US11407721B2 (en) 2013-02-19 2022-08-09 Amgen Inc. CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
AU2014223547B2 (en) 2013-02-28 2017-11-16 Amgen Inc. A benzoic acid derivative MDM2 inhibitor for the treatment of cancer
US9758495B2 (en) 2013-03-14 2017-09-12 Amgen Inc. Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancer
JOP20200296A1 (ar) 2013-06-10 2017-06-16 Amgen Inc عمليات صنع وأشكال بلورية من mdm2 مثبط
CN103435621B (zh) * 2013-07-26 2015-11-04 中国林业科学研究院林产化学工业研究所 螺环喹唑啉衍生物及其制备方法
EP3164401B1 (en) 2014-07-03 2018-12-26 Boehringer Ingelheim International GmbH New spiro[3h-indole-3,2´-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors
DK3183254T3 (da) 2014-08-21 2019-08-19 Boehringer Ingelheim Int Nye spiro[3h-indol-3,2 ?-pyrrolidin]-2(1h)-one forbindelser og derivater som mdm2-p53 inhibitorer
TWI711452B (zh) 2015-02-20 2020-12-01 日商第一三共股份有限公司 癌症的倂用治療法
US10485794B2 (en) 2015-04-13 2019-11-26 Daiichi Sankyo Company, Limited Treatment method by combined use of MDM2 inhibitor and BTK inhibitor
WO2017060431A1 (en) 2015-10-09 2017-04-13 Boehringer Ingelheim International Gmbh Spiro[3h-indole-3,2´-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors
EP3458101B1 (en) 2016-05-20 2020-12-30 H. Hoffnabb-La Roche Ag Protac antibody conjugates and methods of use
CN109843329A (zh) 2016-10-17 2019-06-04 第一三共株式会社 使用mdm2抑制剂和dna甲基转移酶抑制剂的组合治疗方法
EP3511334A1 (en) * 2018-01-16 2019-07-17 Adamed sp. z o.o. 1,2,3',5'-tetrahydro-2'h-spiro[indole-3,1'-pyrrolo[3,4-c]pyrrole]-2,3'-dione compounds as therapeutic agents activating tp53
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same
WO2024240858A1 (en) 2023-05-23 2024-11-28 Valerio Therapeutics Protac molecules directed against dna damage repair system and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007010272A (es) * 2005-02-22 2008-03-12 Univ Michigan Inhibidores de moleculas pequenas de mdm2 y usos de los mismos.
CA2617042A1 (en) * 2005-07-29 2007-02-01 Takeda Pharmaceutical Company Limited Spiro-cyclic compound

Also Published As

Publication number Publication date
WO2008141975A1 (en) 2008-11-27
JP2010527954A (ja) 2010-08-19
MX2009012595A (es) 2009-12-07
BRPI0812155A2 (pt) 2019-09-24
US7834179B2 (en) 2010-11-16
CN101679448A (zh) 2010-03-24
TW200901994A (en) 2009-01-16
US20080293723A1 (en) 2008-11-27
IL202020A0 (en) 2010-06-16
AR066659A1 (es) 2009-09-02
CA2687160A1 (en) 2008-11-27
KR20090130319A (ko) 2009-12-22
EP2152714A1 (en) 2010-02-17
AU2008253117A1 (en) 2008-11-27
ATE549340T1 (de) 2012-03-15
EP2152714B1 (en) 2012-03-14
ES2382139T3 (es) 2012-06-05

Similar Documents

Publication Publication Date Title
PE20090718A1 (es) Derivados de espiroindolinona
PE20060531A1 (es) Derivados de piridazin-3-(2h)-ona como inhibidores de la fosfodiesterasa 4
PE20091095A1 (es) Moduladores de gamma secretasa
PE20081346A1 (es) Derivados de espiroindolinona como antagonistas de mdm2
PE20090279A1 (es) Derivados de 3,3-espiroindolinona como agentes antagonistas de mdm2
PE20080695A1 (es) Derivados de dihidropirazolopirimidinona como inhibidores de quinasa weel
PE20091466A1 (es) Derivados de 4,5-dihidro-oxazol-2-il-amina
TW200720266A (en) Benzodioxane and benzodioxolan derivatives and uses thereof
PE20130012A1 (es) Derivados de pirazol como inhibidores de jak
EA200400466A1 (ru) Производные пиперазина с антагонистической активностью к рецептору ccr1
TW200716595A (en) Chromane and chromene derivatives and uses thereof
ES2299896T3 (es) Derivados de benzazepina como antagonistas h3 de histamina.
CY1113642T1 (el) Γεφυρωμενες δικυκλικες ετεροαρυλ υποκατεστημενες τριαζολες, χρησιμες ως αναστολεις της axl
PE20081845A1 (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
PE20060383A1 (es) Nuevos derivados amino de urea ciclicos como inhibidores de quinasa
PE20070832A1 (es) Derivados de piridazinona como inhibidores de la tirosina quinasa
PE20091268A1 (es) Derivados heterociclicos como inhibidores de pi3 quinasa
MXPA05010621A (es) Pirimidinonas sustituidas.
PE20040647A1 (es) Inhibidores de cinasas de tirosina
PE20110671A1 (es) Derivados de diazabicicloalcanos como moduladores de la actividad de los receptores nicotinicos de la acetilcolina
ECSP10010429A (es) Derivados bicíclicos heterocíclicos o espirobicíclicos heterocíclicos enlazados, de pirazolo[1,5-a]pirimidinas, procedimientos para su preparación y usos de los mismos
TW200719886A (en) Dihydrobenzofuran derivatives and uses thereof
UA100695C2 (ru) 2,3-дигидробензо[1,4] диоксин-2-илметиловые производные как альфа2с антагонисты для применения в лечении заболеваний периферической и центральной нервной системы
PE20080345A1 (es) Derivados de piperazina como agonistas del receptor de gpr38
PE20090944A1 (es) PIRIMIDINAS BICICLICAS FUSIONADAS COMO INHIBIDORES DE LA VIA Pi3K/AKT

Legal Events

Date Code Title Description
FA Abandonment or withdrawal